Popular Pre-Market Trades in US Stocks
eLong Power, up 35.38% in pre-market trading, has no significant recent news. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Agroz, down 24.17% in pre-market trading, has no significant recent news. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Top Gainers in Pre-Market US Stocks
iSpecimen, up 56.56% in pre-market trading, has no significant recent news. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
EON Resources, up 23.70% in pre-market trading. Based on recent key news:
<ol>
<li>
On March 11, EON Resources Inc. implemented hedging measures to cope with rising oil prices, planning to achieve production growth by 2027. This move has boosted market confidence in the company's future performance, driving the stock price up 23.70%. Source: EONR Stock News
</li>
<li>
On March 11, the news brief released by EON Resources Inc. was created using generative artificial intelligence by Public Technologies, emphasizing the company's responsibility for information. This information did not directly affect the stock price but provided background support. Source: ACCESS Newswire
</li>
<li>
No other significant recent news. Rising oil prices have strengthened energy stocks overall.
</li>
</ol>
Oncology Institute, up 16.41% in pre-market trading. Based on recent news,
<ol>
<li>
On March 12, Oncology Institute announced its fourth-quarter financial report. Although the earnings per share were -$0.06 and the net income was -$7.5 million, its revenue reached $142 million, exceeding the market expectation of $139.78 million. This positive news drove the stock price up.
</li>
<li>
On March 12, Oncology Institute announced that it achieved adjusted EBITDA profitability for the first time in the fourth quarter of 2025, with a year-on-year revenue growth of 28%, and strong growth in per capita payment and pharmacy business. This news further enhanced market confidence.
</li>
<li>
On March 11, Oncology Institute collaborated with Tempus AI to release a study demonstrating the advantages of comprehensive genomic analysis in community cancer treatment. The results of this study have raised market expectations for the company's technology and future development. The healthcare industry is performing strongly overall, with increasing market demand for innovative technologies
</li>
</ol>

ELPW

AGRZ

eLong Power pre-market up 35.38%; Agroz pre-market down 24.17%; iSpecimen pre-market up 56.56%; EON Resources pre-market up 23.70%; Oncology Institute pre-market up 16.41%

Pre-market hot trades in US stocks: eLong Power up 35.38% pre-market; Agroz down 24.17% pre-market